Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-767,708
Closed -$45.2M 327
2021
Q4
$45.2M Sell
767,708
-622,213
-45% -$35.7M 0.23% 67
2021
Q3
$76.2M Sell
1,389,921
-721,932
-34% -$40.2M 0.36% 59
2021
Q2
$108M Sell
2,111,853
-282,021
-12% -$14.6M 0.44% 51
2021
Q1
$124M Sell
2,393,874
-677,442
-22% -$37.2M 0.61% 43
2020
Q4
$172M Buy
+3,071,316
New +$164M 1.04% 37
2020
Q3
Sell
-2,716,943
Closed -$123M 131
2020
Q2
$123M Sell
2,716,943
-75,431
-3% -$3.38M 0.99% 34
2020
Q1
$123M Buy
2,792,374
+761,032
+37% +$29.7M 1.06% 31
2019
Q4
$72.8M Buy
+2,031,342
New +$75.5M 0.49% 44

Other funds holding QGEN

Thomas Steyer's QGEN Position: Q1 2022 in Review

Thomas Steyer sold out of Qiagen (QGEN) in Q1 2022, closing a stake of 767,708 shares — an estimated $45.2M sold.

Thomas Steyer first reported a position in QGEN in Q4 2019 and held it in 8 quarters. The position peaked at $172M in Q4 2020. 293 funds tracked by Wall St. Rank hold QGEN as of Q1 2022.

  • Thomas Steyer reported no remaining Qiagen position as of Q1 2022 after selling out during the quarter.
  • Thomas Steyer sold 767,708 Qiagen shares in Q1 2022, an estimated $45.2M.
  • Thomas Steyer first reported a position in Qiagen in Q4 2019 and held it in 8 quarters.
  • Thomas Steyer's Qiagen position peaked at $172M in Q4 2020.
  • 293 funds tracked by Wall St. Rank held Qiagen as of Q1 2022.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.